These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6345298)

  • 1. Cyclosporin A following matched and mismatched family allogeneic bone marrow transplants.
    Powles RL; Morgenstern GR; Leigh M; Filshie J; Platt J; Lumley H
    Haematol Blood Transfus; 1983; 28():87-9. PubMed ID: 6345298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gluckman E; Reiffers J; Vernant JP; Jouet JP; Harrousseau JL; Fiere D; Bacigalupo A; Frassoni F; Gorin NC
    Bone Marrow Transplant; 1996 Nov; 18(5):921-9. PubMed ID: 8932846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation.
    Atkinson K; Biggs JC; Ting A; Concannon AJ; Dodds AJ; Pun A
    Br J Haematol; 1983 Feb; 53(2):265-70. PubMed ID: 6336949
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation in 33 patients with malignant blood diseases and severe aplastic anaemia.
    Biggs J; Atkinson K; Concannon A; Dodds A; Harkness J; Yuile P; Causer P; Bashir H; Penny R; Nicholls M; Ting A; Pun A; Honeyman M
    Med J Aust; 1983 Aug; 2(3):120-5. PubMed ID: 6348501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow transplantation in leukemia and aplastic anemia].
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
    Byrne JL; Stainer C; Hyde H; Miflin G; Haynes AP; Bessell EM; Russell NH
    Bone Marrow Transplant; 1998 Sep; 22(6):541-5. PubMed ID: 9758340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney.
    Atkinson K; Dodds AJ; Concannon AJ; Milliken S; Downs K; Marshall G; Wilson F; Staniforth D
    Aust N Z J Med; 1993 Oct; 23(5):450-7. PubMed ID: 8297273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
    Ringdén O; Bäckman L; Lönnqvist B; Heimdahl A; Lindholm A; Bolme P; Gahrton G
    Bone Marrow Transplant; 1986 May; 1(1):41-51. PubMed ID: 3332119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New development in clinical bone marrow transplantation in leukemia].
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Müller M; Lüthy A; Signer E; Burri HP; Jeannet M
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1975-7. PubMed ID: 7036335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
    Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Bacigalupo A; Van Lint MT; Occhini D; Margiocco M; Ferrari G; Pittaluga PA; Frassoni F; Peralvo J; Lercari G; Carubia F
    Transplantation; 1988 Jun; 45(6):1091-4. PubMed ID: 3289150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.
    Jiang YZ; Kanfer EJ; Macdonald D; Cullis JO; Goldman JM; Barrett AJ
    Bone Marrow Transplant; 1991 Oct; 8(4):253-8. PubMed ID: 1756322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G
    Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin-A in allogeneic bone marrow transplantation for leukemia: Basle experience 1979 to 1984.
    Gratwohl A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):127-32. PubMed ID: 3914737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].
    Huang X; Chen Y; Han W; Chen Y; Hong H; Lu D
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 35(2):115-8. PubMed ID: 12920822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Beelen DW; Quabeck K; Kaiser B; Wiefelspütz J; Scheulen ME; Graeven U; Grosse-Wilde H; Sayer HG; Schaefer UW
    Transplantation; 1990 Sep; 50(3):421-7. PubMed ID: 2402791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia. International Bone Marrow Transplant Registry.
    Lancet; 1989 Mar; 1(8637):535-7. PubMed ID: 2564066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.